MAXCYTE INC's ticker is and the CUSIP is 57777K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,735,271 | -32.0% | 5,043,356 | 0.0% | 4.46% | -5.3% |
| Q2 2023 | $23,149,004 | -7.3% | 5,043,356 | 0.0% | 4.71% | -11.7% |
| Q1 2023 | $24,964,612 | -9.3% | 5,043,356 | 0.0% | 5.33% | -8.0% |
| Q4 2022 | $27,536,724 | -16.0% | 5,043,356 | 0.0% | 5.80% | -0.9% |
| Q3 2022 | $32,782,000 | +37.4% | 5,043,356 | 0.0% | 5.85% | +44.6% |
| Q2 2022 | $23,855,000 | -22.2% | 5,043,356 | +15.0% | 4.04% | +24.3% |
| Q1 2022 | $30,656,000 | -9.7% | 4,385,670 | +31.7% | 3.25% | +84.3% |
| Q4 2021 | $33,933,000 | -16.5% | 3,330,000 | 0.0% | 1.77% | +4.1% |
| Q3 2021 | $40,659,000 | – | 3,330,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |